January 6, 2015
ARLINGTON, Va. — HDMA President and CEO John M. Gray, along with other healthcare supply chain leaders, contributed to Chain Drug Review's annual "Pharmacy Outlook" feature, published on January 5.
In the column, Gray says, "The coming year will mark the continuation of the complex, multi-year effort to implement the transformational Drug Supply Chain Security Act (DSCSA).” In 2014, HDMA worked with industry and government stakeholders to assist distributors in preparing for the first major deadline. “The next implementation milestone will be on-boarding dispensers by July 1, 2015,” remarked Gray.
Along with the continued efforts to implement the national traceability law, Gray outlines additional priorities that will be key in 2015. These include the continuing impact of the nation's prescription drug abuse epidemic, efforts to repeal the last-in, first-out (LIFO) accounting method and the issues facing the pharmaceutical supply chain as it evolves globally. Additionally, Gray makes note of HDMA’s first step into the international arena. After HDMA successfully hosted the International Pharmaceutical Distribution Conference in Beijing, the coming year will likely bring another international meeting, with the organization’s sights set on Europe.Download PDF
HDA is the national association representing primary healthcare distributors, the vital link between the nation’s pharmaceutical manufacturers and healthcare providers. Each business day, HDA member companies ensure that over 15 million prescription medicines and healthcare products are delivered safely and efficiently to more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation’s healthcare system.